CareView Communications (CRVW) Cash from Investing Activities (2010 - 2026)
CareView Communications' (CRVW) quarterly Cash from Investing Activities came in at -$21466.0 in Q2 2026, down 549.5% year-over-year from $4775.5 in Q2 2025, and down 131.26% quarter-over-quarter from -$9282.0 in Q1 2026.
Powered by 
Analysis
CareView Communications (CRVW) Cash from Investing Activities (2010 - 2026) Analysis & Trends
CareView Communications has disclosed Cash from Investing Activities across 17 years of filings, most recently posting -$21466.0 for Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 549.5% year-over-year to -$21466.0; the TTM figure through Jun 2026 stood at -$43928.0 (down 160.66% YoY), while the FY2025 annual figure was -$17567.0, up 76.11% from the prior year.
- Cash from Investing Activities came in at -$21466.0 for Q2 2026 at CareView Communications, down from -$9282.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $58260.0 in Q4 2022 to a low of -$128056.0 in Q2 2024.
- Average Cash from Investing Activities over 5 years is -$12504.3, with a median of -$7339.0 recorded in 2022.
- Year-over-year, Cash from Investing Activities surged 1992.67% in 2022 and sank 757.86% in 2026.
- Over 5 years, Cash from Investing Activities stood at $58260.0 in 2022, then slumped by 196.17% to -$56026.0 in 2023, then surged by 201.52% to $56875.0 in 2024, then retreated by 23.18% to $43692.0 in 2025, then sank by 149.13% to -$21466.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$21466.0 in Q2 2026, -$9282.0 in Q1 2026, and $43692.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -383.65 Mn |
| 10 | CareView Communications | 23.36 Mn | 21.44 Mn | - | -21,466.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21,466.00 |
| Mar 31, 2026 | -9,282.00 |
| Dec 31, 2025 | 43,692.00 |
| Sep 30, 2025 | -56,872.00 |
| Jun 30, 2025 | -3,305.00 |
| Mar 31, 2025 | -1,082.00 |
| Dec 31, 2024 | 56,875.00 |
| Sep 30, 2024 | 19,928.00 |
| Jun 30, 2024 | -128,056.00 |
| Mar 31, 2024 | -22,281.00 |
| Dec 31, 2023 | -56,026.00 |
| Sep 30, 2023 | -4,501.00 |
| Dec 31, 2022 | 58,260.00 |
| Sep 30, 2022 | -7,339.00 |
| Mar 31, 2022 | -56,110.00 |
| Dec 31, 2021 | 2,784.00 |
| Sep 30, 2021 | -176,430.00 |
| Dec 31, 2020 | 2,137.00 |
| Sep 30, 2020 | -36,316.00 |
| Jun 30, 2020 | -157,854.00 |